October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
ASCO Direct Best of Oncology Conference speaker spotlight: Christian Rolfo – Cincinnati Cancer Advisors
Oct 26, 2024, 15:40

ASCO Direct Best of Oncology Conference speaker spotlight: Christian Rolfo – Cincinnati Cancer Advisors

Cincinnati Cancer Advisors posted on LinkedIn:

ASCO Direct Best of Oncology Conference speaker spotlight: Christian Rolfo.

Christian Rolfo is Professor of Medicine at the Ohio State University, School of Medicine. He is serving as Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at The James Comprehensive Cancer Center at OSU, in Columbus, OH.  Before joining OSU, he was serving as Professor at Mount Sinai School of Medicine and Associate Director for Clinical Research in the Center for Thoracic Oncology at The Tisch Cancer Institute. Dr. Rolfo’s clinical and research focus is on drug development, lung cancer and other thoracic malignancies, biomarkers, resistant mechanisms discovery, and liquid biopsies.

Still need to register for our November 2nd conference? Please visit here.”

Douglas Flora shared this post on LinkedIn, adding:

“Sharing for reach: Look at this all-star lineup for Cincinnati and Northern Kentucky friends. It’s still possible to sign up. Thanks to Abdul Rahman Jazieh and Bill Barrett and Cincinnati Cancer Advisors for continuing to innovate and educate the cancer fighters in our region.”

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.